Siemens Medical Systems Inc.
Division of Siemens AG
Latest From Siemens Medical Systems Inc.
Exec Chat: Philips's Bert Van Meurs Discusses Innovation And Plans For Image-Guided Therapy Business Unit
This year, Bert van Meurs, chief business leader of Philips's image-guided therapy business, has led two major product launches and a new partnership with Microsoft to combine Philips's Azurion angiographic platform with Microsoft's HoloLens 2 mixed-reality (MR) technology. Medtech Insight caught up with van Meurs to learn more about Azurion, the continued role of machine learning and MR, the overall business strategy and competitive landscape.
Stereotaxis began as a research project--developing a magnetic surgical guidance system--that serendipitously became a company without much regard for commercial prospects. The original design was ahead of the technology curve, but innovations in magnetic and imaging systems fortuitously enabled Stereotaxis to turn this concept into a product. The company's system, however, was and still remains far ahead of the necessary adjunctive drugs and devices necessary to become a viable therapeutic tool in neurology, the area Stereotaxis first sought to pursue. Looking for applications in other specialties for what it believes is a platform technology, Stereotaxis shifted its focus to cardiology. The company launched a system that has been well-received in the small but growing area of electrophysiology. Most recently, Stereotaxis has begun to focus on what could be its most significant opportunity: interventional cardiology. Here, too, the company appears to be the beneficiary of good timing: in the era of drug-eluting stents, interventionalists are likely to treat more difficult patients, the cases that could benefit most from Stereotaxis' advanced guidance system. The company's system, however, was and still remains far ahead of the adjunctive drugs and devices necessary to become a viable therapeutic tool in neurology, the area Stereotaxis first sought to pursue.
The $2 billion acquisition by GE Medical Systems of Helsinki, Finland-based Instrumentarium Corp., the largest medical device deal of 2002, has obvious implications for the patient monitoring market in which both companies have major stakes. The deal also is likely to have a significant future impact on driving the growth of the digital mammography market.
Intraoperative imaging using MRI brings real-time imaging into the neurosurgical suite, complementing other methods of helping neurosurgeons visualize their operating fields. Neurosurgical interest seems high, but with the technology new and extremely expensive, adoption rates are at a crawl. Two big players, Siemens and GE, are in the market. Now, Odin Medical, an Israeli start-up, is offering a lower cost, but less powerful system that it says is more practical and adequate for neurosurgeon's needs. A new deal with Medtronic's Surgical Navigation Technologies division should help drive sales.
- Medical Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Siemens AG
- Senior Management
Thomas McCausland, Pres. & CEO
Guenter Westermann, SVP
Dennis Falkenstein, VP, Sales & Mktg.
- Contact Info
Siemens Medical Systems Inc.
Phone: (201) 321-4500
186 Wood Avenue South
Iselin, NJ 08830-
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.